Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Gain Therapeutics (GANX) has shared an update.
Gene Mack has been appointed as the new Chief Financial Officer of Gain Therapeutics, Inc., effective April 8, 2024. Bringing a wealth of experience from leading financial roles in several biotech companies, Mack’s responsibilities will include overseeing the company’s financial operations and serving as Secretary. His compensation package includes a $370,000 base salary, potential cash bonuses, and an option to purchase company stock, with provisions for severance under certain conditions. Mack’s appointment is expected to bring seasoned leadership to Gain Therapeutics’ financial strategy as it continues to innovate in the biotechnology sector.
See more insights into GANX stock on TipRanks’ Stock Analysis page.
